METAVIA INC (MTVA)
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
$1.75-4.89%
Close 2026-09-04 · 1-day change
NASDAQHealth CareBiotechnologySnapshot 2026-09-04
QuarterlyIQ Insights · MTVA
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of USD, except per-share and ratios.
| TTM | Dec 2025 | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Expenses & Income | |||||||||||
| R&D Expenses | 7.7 | 6.8 | — | — | — | — | — | — | — | — | — |
| Operating Income | (14.9) | (13.7) | (28.8) | (15.9) | (19.6) | (15.3) | (29.7) | (20.2) | (15.5) | (33.1) | (14.7) |
| Earnings from Continuing Operations | |||||||||||
| EBT, Incl. Unusual Items | (14.4) | (13.0) | (27.6) | (12.5) | (14.0) | (15.3) | (29.7) | (21.3) | (15.5) | (33.4) | (14.6) |
| Income Tax Expense | — | — | — | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Net Income | |||||||||||
| Net Income | (14.4) | (13.0) | (27.6) | (12.5) | (14.0) | (15.3) | (29.7) | (21.3) | (15.5) | (33.4) | (14.6) |
| Per Share | |||||||||||
| Basic EPS | (2.44) | (7.35) | (3.56) | (2.46) | (43.42) | (19.81) | (1.83) | — | — | — | — |
| Diluted EPS | (2.44) | (7.35) | (3.56) | (2.46) | (43.42) | (19.81) | (1.83) | — | — | — | — |
| Basic Weighted Avg Shares | 5.9 | 1.8 | 7.8 | 5.1 | 0.3 | 0.8 | 16.2 | — | — | — | — |
| Diluted Weighted Avg Shares | 5.9 | 1.8 | 7.8 | 5.1 | 0.3 | 0.8 | 16.2 | — | — | — | — |
| Supplemental | |||||||||||
| EBIT | (14.9) | (13.7) | (28.8) | (15.9) | (19.6) | (15.3) | (29.7) | (20.2) | (15.5) | (33.1) | (14.7) |
| Effective Tax Rate | — | — | — | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.